P3 Health Partners, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Paymentus Holdings, Inc.

TaskUs, Inc.

Willdan Group, Inc.

InfuSystem Holdings, Inc.

Information Services Group, Inc.

Universal Technical Institute, Inc.

Lincoln Educational Services Corp.

Emerald Holding, Inc.

Augmedix, Inc.

P3 Health Partners, Inc.

PMV Pharmaceuticals, Inc.

Why is P3 Health Partners, Inc. ?

The company has declared Negative results for the last 4 consecutive quarters

NET PROFIT(9M) At USD -104.21 MM has Grown at -58.3%
OPERATING CASH FLOW(Y) Lowest at USD -129.96 MM
RAW MATERIAL COST(Y) Grown by 87.46% (YoY)

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -44.94%, its profits have fallen by -75.5%

Below par performance in long term as well as near term

Along with generating -44.94% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is P3 Health Partners, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

P3 Health Partners, Inc.

-56.49%

0.14

5866.03%

S&P 500

13.01%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

518.44%

EBIT Growth (5y)

-507.03%

EBIT to Interest (avg)

-14.52

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

2.07

Sales to Capital Employed (avg)

1.33

Tax Ratio

1.12%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

25.63%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.75

EV to EBIT

-0.58

EV to EBITDA

-0.81

EV to Capital Employed

0.92

EV to Sales

0.12

PEG Ratio

Dividend Yield

ROCE (Latest)

-158.28%

ROE (Latest)

-509.38%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

PRE-TAX PROFIT(Q)

At USD -43.69 MM has Grown at 45.19%

NET PROFIT(Q)

At USD -22.36 MM has Grown at 42.21%

EPS(Q)

Highest at USD -6.23

-20What is not working for the Company

NET PROFIT(9M)

At USD -104.21 MM has Grown at -58.3%

OPERATING CASH FLOW(Y)

Lowest at USD -129.96 MM

RAW MATERIAL COST(Y)

Grown by 87.46% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 345.02 %

NET SALES(Q)

Lowest at USD 355.79 MM

INTEREST(Q)

Highest at USD 10.14 MM

Here's what is working for P3 Health Partners, Inc.

Pre-Tax Profit

At USD -43.69 MM has Grown at 45.19%

over average net sales of the previous four periods of USD -79.7 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -22.36 MM has Grown at 42.21%

over average net sales of the previous four periods of USD -38.7 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

EPS

Highest at USD -6.23

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for P3 Health Partners, Inc.

Interest

At USD 10.14 MM has Grown at 16.28%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Cash Flow

Lowest at USD -129.96 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Sales

Lowest at USD 355.79 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Interest

Highest at USD 10.14 MM

in the last five periods and Increased by 16.28% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at 345.02 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 87.46% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales